Press release
Personalized Cancer Vaccines Market Expansion Continues, with Forecast Valuation of $336.03 Billion by 2029
Personalized Cancer Vaccines
Personalized Cancer Vaccines Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market for personalized cancer vaccines has seen robust growth. Projected to rise from a worth of $242.29 billion in 2024 to $259.11 billion in 2025, it will grow at a compound annual growth rate (CAGR) of 6.9%. This growth during the historical period is as a result of significant strides made in genomic research, the development of targeted therapies, heightened knowledge on tumor immunology, advancements in vaccine technology, and an increase in clinical trial data that supports efficacy.
Personalized Cancer Vaccines Market Size Forecast: What's the Projected Valuation by 2029?
In the forthcoming years, it is anticipated that the personalized cancer vaccines market will witness significant growth, expanding to a market size of $336.03 billion by 2029 with a compound annual growth rate (CAGR) of 6.7%. This expected growth during the forecast period can be tied to several factors including advances in precision medicine, increased funding allocated for cancer research, a rising number of reported cancer cases, enhancements in genetic sequencing technologies, and the increasing popularity of personalized treatment approaches. The forecast period is also likely to see certain trends emerging such as the incorporation of artificial intelligence in vaccine development, progression in multi-antigen and neoantigen-based vaccines, growing application of liquid biopsies in tracking tumors, broadening of combination therapies, and an increased emphasis on personalized treatment plans.
View the full report here:
https://www.thebusinessresearchcompany.com/report/personalized-cancer-vaccines-global-market-report
What Are the Drivers Transforming the Personalized Cancer Vaccines Market?
The rise in cancer instances is predicted to fuel the expansion of the personalized cancer vaccine market. Cancer is defined as a group of illnesses characterized by abnormal cell proliferation that can metastasize to other body regions. The escalating incidence of cancer is attributable to factors such as senior populations, lifestyle modifications, environmental contaminants, genetic susceptibility, and enhanced diagnostic methods. Personalized cancer vaccines aim to curb the escalating cancer instances by focusing on distinct tumor antigens exclusive to each patient, thus improving the immune system's capacity to identify and eliminate cancer cells. For illustration, the Australian Institute of Health and Welfare, an Australian government entity, reported in July 2024 that cancer diagnoses in Australia jumped from 160,570 in 2022 to 164,694 in 2023, indicating a significant yearly increase. Consequently, the rising prevalence of cancer is a driving factor for the expansion of the personalized cancer vaccine market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19136&type=smp
What Long-Term Trends Will Define the Future of the Personalized Cancer Vaccines Market?
Leading businesses in the personalized cancer vaccine market are aiming to develop innovative therapeutic approaches, such as personalized immunotherapy, to increase accuracy in treating distinct cancer mutations. These personalized immunotherapy treatments are tailored according to each patient's distinctive genetic and tumour traits to boost immune responses to cancer. For example, in August 2024, a groundbreaking clinical trial to assess a cancer vaccine's safety and efficacy was initiated by UCLA Health, a healthcare organization based in the US. The vaccine, concocted by UCLA, uses a personalized immunotherapy technique that targets the H3 G34 mutation found in diffuse hemispheric gliomas, a highly aggressive brain tumour prevalent in teenagers and young adults. The strategy utilizes dendritic cells in a unique way to stimulate the immune system against the specific RNA disturbances caused by this mutation. This method, having demonstrated potential in curing other types of cancer, strives to enhance results for patients who normally have access to very few treatment alternatives and have short expected lifespans.
Which Segments in the Personalized Cancer Vaccines Market Offer the Most Profit Potential?
The personalized cancer vaccinesmarket covered in this report is segmented -
1) By Treatment Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma
3) By Mechanism Of Action: Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action
4) By Route Of Administration: Injectables, Other Routes Of Administration
5) By End Use: Hospitals, Clinic, Other End Users
Subsegments:
1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines, Combination Vaccines
2) By Therapeutic Cancer Vaccines: Dendritic Cell Vaccines, Peptide-Based Vaccines, DNA Vaccines, RNA Vaccines, Whole Cell Vaccines
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19136&type=smp
Which Firms Dominate the Personalized Cancer Vaccines Market by Market Share and Revenue in 2025?
Major companies operating in the personalized cancer vaccines market are Merck & Co Inc., GlaxoSmithKline Plc, NEC Corporation, Moderna Inc., Catalent Inc., UCLA Health, Genetech Inc., NHS England, CureVac AG, Personalis Inc., Achilles Therapeutics Plc, Healio, Moffitt Corporation, BioPharma APAC, Celebrity Angels, EpiVax Therapeutics Inc., Evaxion Biotech AS, Geneos Therapeutics Inc., IFL Sciense, ISA Pharmaceuticals BV, Oxford Global, Kintara Therapeutics, VAXIMM Gmbh
Which Regions Offer the Highest Growth Potential in the Personalized Cancer Vaccines Market?
North America was the largest region in the personalized cancer vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19136
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Personalized Cancer Vaccines Market Expansion Continues, with Forecast Valuation of $336.03 Billion by 2029 here
News-ID: 4147118 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
